Navigation Links
TrialNetworks Co-founder and Chairman Vivek Murthy, MD, MBA, Nominated by President Barack Obama as Surgeon General of the United States of America
Date:11/15/2013

Needham, MA (PRWEB) November 15, 2013

TrialNetworks Co-founder and Chairman Vivek Murthy, MD, MBA, has been nominated to serve as the 19th Surgeon General of the United States of America by President Barack Obama.

Dr. Murthy is currently an attending physician at Brigham and Women’s Hospital and an instructor at Harvard Medical School. In 2011, President Obama appointed Dr. Murthy to the Advisory Group on Prevention, Health Promotion, and Integrative and Public Health. His past research has focused on the participation of women and minorities in cancer clinical trials, and his writings and research have been published in Science, Journal of the American Medical Association (JAMA), Journal of the National Cancer Institute, and The Washington Post.

Based on his lifelong commitment to patient wellness and his conviction that modern technology can be used to enhance collaboration among clinical researchers to accelerate drug discovery, Dr. Murthy co-founded TrialNetworks with CEO Eric Silberstein (his Harvard University classmate) and CTO Ezra Freedman.

“Dr. Murthy’s focus has always been on using his experience in medicine and science to find ways to help patients and improve healthcare on a broad scale,” said Silberstein. “His vision and insights led to the creation of TrialNetworks and our Clinical Trial Optimization System, which enables pharmaceutical companies to bring novel therapies to patients faster by running more efficient and higher-quality trials. It is exciting and an honor that Dr. Murthy will now have such a public platform to share and apply his expertise to benefit the health and wellness of individuals across our nation.”

TrialNetworks customers and clinical operations executives who know Dr. Murthy agree.

“Having worked with TrialNetworks for years, Dr. Murthy’s passion for improving the clinical research process is inspiring,” said Dr. Murray Abramson, MD, MPH, Vice President of Global Clinical Operations at Biogen Idec. “As a study sponsor and drug developer, I appreciate how TrialNetworks invests in its customer relationships and partners with us to create innovative technology that helps solve our clinical operational challenges. We wish him the best of luck in his new post.”

Upon confirmation by the U.S. Senate, Dr. Murthy will step down as Chairman of TrialNetworks.

Added Silberstein, “On behalf of TrialNetworks and our customers, I would like to thank Dr. Murthy for his years of guidance and friendship and congratulate him on this well-earned and honored nomination as America’s Doctor.”

About TrialNetworks
TrialNetworks provides sponsors and CROs the industry's only Clinical Trial Optimization System. Using this modern and intuitive technology, customers such as Merck & Co. and Infinity Pharmaceuticals are able to transform the quality and efficiency of clinical operations at each stage of a trial from feasibility through closeout. TrialNetworks apps, including Checklist™, Training™, Document Library™, Visit Guide™, Action Items™ and Directory™, are available in a unified and secure cloud-based interface. Customers ranging from biotechs to Top-10 pharma companies have implemented the TrialNetworks platform for use in Phase I-IV trials by more than 25,000 site staff in 60 countries. To learn why sponsors and CROs rely on TrialNetworks to optimize clinical trial operations, request a guided online demo at http://www.trialnetworks.com.

Read the full story at http://www.prweb.com/releases/2013/11/prweb11340044.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. TrialNetworks Customer to Present Results of Using Site Engagement Technology to Improve Study Operations and Patient Enrollment at Clinical Trial Optimization Conference
2. TrialNetworks Feasibility Survey™ App Gets ARIAD Pharmaceuticals Unprecedented 75% Response from Potential Clinical Trial Investigator Sites
3. TrialNetworks Sees Strong Growth in Demand for its Clinical Trial Optimization System as Pharma Seeks Technology to Improve Operations Quality and Efficiency
4. Telome Health Co-founder and Nobel Laureate Elizabeth Blackburn Awarded Innovator of the Year
5. AMS Co-Founder John Hauser Receives Lifetime Achievement Award
6. InspireMD Elects Sol J. Barer, Ph.D. Chairman of the Board of Directors
7. Fate Therapeutics Announces the Appointment of William H. Rastetter as Chairman of its Board of Directors and Interim CEO
8. Kevin Sharer, Amgen Chairman and CEO, Announces Plan to Retire With Robert Bradway to Become CEO on May 23, 2012; Sharer Will Continue as Chairman of the Board Until End of 2012
9. Inovios Scientific Advisory Board Chairman Elected as a Fellow by the American Association for the Advancement of Science
10. Amarillo Biosciences Appoints Dr. Stephen Chen as Chairman and CEO
11. PAREXEL Chairman and CEO to Deliver Keynote at MassBio CRO/CMO Symposium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... ... May 25, 2016 , ... The American Medical ... Office of the National Coordinator for Health IT (ONC) outlining a measurement approach ... data were available when and where it was needed. The organization of health ...
(Date:5/25/2016)... ... May 25, 2016 , ... Lady had been battling ... her cruciate ligament in her left knee. Lady’s owner Hannah sought the help of ... board-certified veterinary surgeon, to repair her cruciate ligament and help with the pain of ...
(Date:5/24/2016)... AVIV, Israel , May 24, 2016   MedyMatch ... providing physicians with artificial intelligence, real-time decision support tools in ... to present at the 2016 Israeli Advanced Technology Industries (IATI) ... of Israel,s 15th National Life Sciences ... 26th at the David Intercontinental Hotel in Tel ...
(Date:5/23/2016)... (PRWEB) , ... May 23, 2016 , ... The need for blood donations in South ... week by the South Texas Blood & Tissue Center, blood donations are on the decline. ... years, and they are down 21 percent in South Texas in the last four years ...
Breaking Biology Technology:
(Date:3/31/2016)... 2016  Genomics firm Nabsys has completed a financial ... Bready , M.D., who returned to the company in ... leadership team, including Chief Technology Officer, John Oliver ... Nurnberg and Vice President of Software and Informatics, ... Dr. Bready served as CEO of Nabsys from ...
(Date:3/23/2016)... Massachusetts , March 23, 2016 /PRNewswire/ ... im Interesse erhöhter Sicherheit Gesichts- und Stimmerkennung ... Xura, Inc. (NASDAQ: MESG ), ... bekannt, dass das Unternehmen mit SpeechPro zusammenarbeitet, ... aus der Finanzdienstleistungsbranche, wird die Möglichkeit angeboten, ...
(Date:3/22/2016)... , PROVO and ... -- Newborn Screening Ontario (NSO), which operates the highest ... for molecular testing, and Tute Genomics and UNIConnect, leaders ... technology respectively, today announced the launch of a project ... sequencing (NGS) testing panel. NSO has ...
Breaking Biology News(10 mins):